Control of the Unfolded Protein Response in Health and Disease

被引:38
作者
Doultsinos, Dimitrios [1 ,2 ]
Avril, Tony [1 ,2 ]
Lhomond, Stephanie [3 ]
Dejeans, Nicolas [3 ]
Guedat, Philippe [4 ]
Chevet, Eric [1 ,2 ,3 ]
机构
[1] Univ Rennes 1, Inserm U1242, Chem Oncogenesis Stress & Signaling, Rennes, France
[2] Ctr Lutte Canc Eugene Marquis, Rennes, France
[3] Bergonie Canc Inst, BMYscreen, Bordeaux, France
[4] Inflectis Biosci, Nantes, France
关键词
endoplasmic reticulum; stress; UPR; pharmacology; screening; ENDOPLASMIC-RETICULUM STRESS; AMYOTROPHIC-LATERAL-SCLEROSIS; GLUCOSE-REGULATED PROTEINS; BZIP TRANSCRIPTION FACTORS; INDUCED XBP1 ACTIVATION; ER QUALITY-CONTROL; DISULFIDE-ISOMERASE; MESSENGER-RNA; ENDORIBONUCLEASE ACTIVITY; SELECTIVE-INHIBITION;
D O I
10.1177/2472555217701685
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The unfolded protein response (UPR) is an integrated, adaptive biochemical process that is inextricably linked with cell homeostasis and paramount to maintenance of normal physiological function. Prolonged accumulation of improperly folded proteins in the endoplasmic reticulum (ER) leads to stress. This is the driving stimulus behind the UPR. As such, prolonged ER stress can push the UPR past beneficial functions such as reduced protein production and increased folding and clearance to apoptotic signaling. The UPR is thus contributory to the commencement, maintenance, and exacerbation of a multitude of disease states, making it an attractive global target to tackle conditions sorely in need of novel therapeutic intervention. The accumulation of information of screening tools, readily available therapies, and potential pathways to drug development is the cornerstone of informed clinical research and clinical trial design. Here, we review the UPR's involvement in health and disease and, beyond providing an in-depth description of the molecules found to target the three UPR arms, we compile all the tools available to screen for and develop novel therapeutic agents that modulate the UPR with the scope of future disease intervention.
引用
收藏
页码:787 / 800
页数:14
相关论文
共 147 条
[1]   ATF6 Is a Transcription Factor Specializing in the Regulation of Quality Control Proteins in the Endoplasmic Reticulum [J].
Adachi, Yusuke ;
Yamamoto, Keisuke ;
Okada, Tetsuya ;
Yoshida, Hiderou ;
Harada, Akihiro ;
Mori, Kazutoshi .
CELL STRUCTURE AND FUNCTION, 2008, 33 (01) :75-89
[2]   Activating transcription factor 4 [J].
Ameri, Kurosh ;
Harris, Adrian L. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (01) :14-21
[3]   The signalling from endoplasmic reticulum-resident bZIP transcription factors involved in diverse cellular physiology [J].
Asada, Rie ;
Kanemoto, Soshi ;
Kondo, Shinichi ;
Saito, Atsushi ;
Imaizumi, Kazunori .
JOURNAL OF BIOCHEMISTRY, 2011, 149 (05) :507-518
[4]   Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity [J].
Atkins, Charity ;
Liu, Qi ;
Minthorn, Elisabeth ;
Zhang, Shu-Yun ;
Figueroa, David J. ;
Moss, Katherine ;
Stanley, Thomas B. ;
Sanders, Brent ;
Goetz, Aaron ;
Gaul, Nathan ;
Choudhry, Anthony E. ;
Alsaid, Hasan ;
Jucker, Beat M. ;
Axten, Jeffrey M. ;
Kumar, Rakesh .
CANCER RESEARCH, 2013, 73 (06) :1993-2002
[5]   Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma [J].
Auf, Gregor ;
Jabouille, Arnaud ;
Guerit, Sylvaine ;
Pineau, Raphael ;
Delugin, Maylis ;
Bouchecareilh, Marion ;
Magnin, Noel ;
Favereaux, Alexandre ;
Maitre, Marlene ;
Gaiser, Timo ;
von Deimling, Andreas ;
Czabanka, Marcus ;
Vajkoczy, Peter ;
Chevet, Eric ;
Bikfalvi, Andreas ;
Moenner, Michel .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (35) :15553-15558
[6]   Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development [J].
Axten, Jeffrey M. ;
Romeril, Stuart P. ;
Shu, Arthur ;
Ralph, Jeffrey ;
Medina, Jesus R. ;
Feng, Yanhong ;
Li, William Hoi Hong ;
Grant, Seth W. ;
Heerding, Dirk A. ;
Minthorn, Elisabeth ;
Mencken, Thomas ;
Gaul, Nathan ;
Goetz, Aaron ;
Stanley, Thomas ;
Hassell, Annie M. ;
Gampe, Robert T. ;
Atkins, Charity ;
Kumar, Rakesh .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (10) :964-968
[7]   Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) [J].
Axten, Jeffrey M. ;
Medina, Jesus R. ;
Feng, Yanhong ;
Shu, Arthur ;
Romeril, Stuart P. ;
Grant, Seth W. ;
Li, William Hoi Hong ;
Heerding, Dirk A. ;
Minthorn, Elisabeth ;
Mencken, Thomas ;
Atkins, Charity ;
Liu, Qi ;
Rabindran, Sridhar ;
Kumar, Rakesh ;
Hong, Xuan ;
Goetz, Aaron ;
Stanley, Thomas ;
Taylor, J. David ;
Sigethy, Scott D. ;
Tomberlin, Ginger H. ;
Hassell, Annie M. ;
Kahler, Kirsten M. ;
Shewchuk, Lisa M. ;
Gampe, Robert T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7193-7207
[8]   The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression [J].
B'chir, Wafa ;
Maurin, Anne-Catherine ;
Carraro, Valerie ;
Averous, Julien ;
Jousse, Celine ;
Muranishi, Yuki ;
Parry, Laurent ;
Stepien, Georges ;
Fafournoux, Pierre ;
Bruhat, Alain .
NUCLEIC ACIDS RESEARCH, 2013, 41 (16) :7683-7699
[9]   Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models [J].
Barmada, Sami J. ;
Serio, Andrea ;
Arjun, Arpana ;
Bilican, Bilada ;
Daub, Aaron ;
Ando, D. Michael ;
Tsvetkov, Andrey ;
Pleiss, Michael ;
Li, Xingli ;
Peisach, Daniel ;
Shaw, Christopher ;
Chandran, Siddharthan ;
Finkbeiner, Steven .
NATURE CHEMICAL BIOLOGY, 2014, 10 (08) :677-U119
[10]   High-throughput Screening Identifies Aclacinomycin as a Radiosensitizer of EGFR-Mutant Non-Small Cell Lung Cancer [J].
Bennett, Daniel C. ;
Charest, Jonathan ;
Sebolt, Katrina ;
Lehrman, Mark ;
Rehemtulla, Alnawaz ;
Contessa, Joseph N. .
TRANSLATIONAL ONCOLOGY, 2013, 6 (03) :382-391